Clinical Trials · NCT00916916

Lanreotide Levels in Acromegaly

UnknownN/ALanreotide (Unclear)
Phase
N/A
Recruitment status
Unknown
Sponsor
Cedars-Sinai Medical Center
Enrollment
0
Start date
Not specified
Locations
1 site, United States
Primary endpoint
Study in Acromegaly
View Lanreotide compound reference